Ethyl 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate, 97.0%, 1g

Closing caps LABOCAP for 28/30 mm 100 pcs

(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol>98.0%(GC)1g

iScope IS.1158-PLPHi Biocular for phase contrast with Plan phase IOS objectives and Rackless cross stage (infinity - ergonomic tilting head)

3-bromo-4-methyl-1,8-naphthyridine, 95.0%, 500mg

Pentamethylene Bis[4-(10,15,20-triphenylporphyrin-5-yl)benzoate]dizinc(II) [Reagent for application of the exciton chirality method]>97.0%(HPLC)10mg

N2-(tert-Butoxycarbonyl)-4-fluoro-1,2-phenylenediamine>98.0%(GC)(T)1g

2-(2-Fluoro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

4-Chloro-2-methylpyrimidin-5-amine, 95.0%, 1g

2-(Difluoromethoxy)pyridin-4-ol, 95.0%, 250mg

5-Amino-pyrimidine-4-carboxylic acid, 95.0%, 250mg

3-(3,4-DIFLUOROPHENYL)-1,2-OXAZOL-5-AMINE, 95.0%, 500mg

2-Bromo-[1,2,4]triazolo[1,5-a]pyridin-6-amine, 250mg